HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B

被引：0
|
作者：
Sonneveld, Milan J. [1 ]
Rijckborst, Vincent [1 ]
Zoutendijk, Roeland [1 ]
Gerken, Guido [2 ]
Tabak, Fehmi [3 ]
Mach, Tomasz H. [4 ]
Boucher, Charles A. [1 ]
Hansen, Bettina E. [1 ]
Janssen, Harry L. [1 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands
[2] Univ Essen Gesamthsch, Essen, Germany
[3] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey
[4] Coll Med UJ, Krakow, Poland
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1030A / 1030A
页数：1
相关论文
共 50 条
  • [31] Clearance of HCV at 5 year follow-up for peginterferon alfa-2b ± ribavirin is predicted by sustained virologic response at 24 weeks post treatment
    Lindsay, Karen
    Manns, Michael P.
    Gordon, Stuart C.
    Pockros, Paul
    Haussinger, Dieter
    Hadziyannis, Stephanos J.
    Schmidt, Warren N.
    Jacobson, Ira M.
    Barcena, Rafael
    Schiff, Eugene
    Shaikh, Obaid S.
    Bacon, Bruce R.
    Marcellin, Patrick
    Smith, Coleman I.
    McHutchison, John G.
    Deng, Weipeng
    Pedicone, Lisa D.
    Albrecht, Janice
    GASTROENTEROLOGY, 2008, 134 (04) : A772 - A772
  • [32] Long-term follow-up of HBeAg-positive young adult Japanese patients treated with corticosteroid withdrawal therapy for chronic hepatitis B
    Sezaki, Hitorni
    Suzuki, Fumitaka
    Hosaka, Tetsuya
    Akuta, Norio
    Someya, Takashi
    Kobayashi, Masahiro
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    INTERVIROLOGY, 2006, 49 (06) : 339 - 345
  • [33] Long-Term Follow-up of Peginterferon α-2b (40kD, Y Shape) (Pegberon) Treatment of Hbeag-Positive Chronic Hepatitis B Patients in Phase III Study
    Wang, Guiqiang
    Hou, Fengqin
    Zhang, Mingxiang
    Zhang, Dazhi
    Peng, Yanzhong
    Shang, Jia
    Chen, Shijun
    Gong, Guozhong
    Chen, Yongping
    Wang, Maorong
    Pan, Chen
    Xie, Qing
    Zhao, Wei
    Liu, Jiajun
    Peng, Jie
    Mao, Qing
    Yin, Chibiao
    Zhang, Jiming
    Zhen, Zhen
    Chen, Liang
    Tan, Deming
    Wang, Hao
    Mao, Qianguo
    Meng, Qinghua
    Chen, Chengwei
    Sun, Li
    HEPATOLOGY, 2018, 68 : 250A - 251A
  • [34] SERUM HBSAG LEVELS DURING PEGINTERFERON ALFA-2A TREATMENT IN HBEAG-POSITIVE CHRONIC HEPATITIS B: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
    Kim, Bo Hyun
    Kim, Won
    Song, Fun Young
    Park, Myoung Hee
    Yoon, Jung-Hwan
    Lee, Youn Jae
    Park, Sung Jae
    Jung, Eun Uk
    Kim, Donghee
    Kim, Yoon Jun
    Lee, Hyo-Suk
    HEPATOLOGY, 2010, 52 (04) : 514A - 514A
  • [35] BASELINE HBSAG LEVELS PREDICT HBSAG LOSS IN HBEAG NEGATIVE BUT NOT IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA): AN INTERIM ANALYSIS
    Takkenberg, Bart
    Zaaijer, Hans L.
    de Niet, Annikki
    Weegink, Christine J.
    Terpstra, Valeska
    Koot, Maarten
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2009, 50 (04) : 536A - 537A
  • [36] Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b
    Schechter, Barry A.
    Koreishi, Aaleya F.
    Karp, Carol L.
    Feuer, William
    OPHTHALMOLOGY, 2008, 115 (08) : 1291 - 1296
  • [37] HBeAg INDEX AND HBV DNA REDUCTION CAN PREDICT LONG TERM RESPONSE OF CHRONIC HEPATITIS B, HBeAg POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2a: A THREE-YEAR FOLLOW-UP
    Phisalprapa, P.
    Charatcharoenwitthaya, P.
    Chainuwatti, S.
    Chotiyaputta, W.
    Nimanong, S.
    Tanwandee, T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S203 - S204
  • [38] HBSAG DECLINE IN HBEAG-NEGATIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2A IS ASSOCIATED WITH SUSTAINED RESPONSE UP TO 5 YEARS POST-TREATMENT: PATIENTS WITH CONTINUOUS HBSAG DECLINE STARTING BEFORE WEEK 24 ACHIEVE HIGHEST RATES OF RESPONSE
    Brunetto, Maurizia R.
    Marcellin, Patrick
    Bonino, Ferruccio
    Kapprell, Hans-Peter
    Messinger, Diethelm
    Batrla, Richard
    HEPATOLOGY, 2009, 50 (04) : 519A - 519A
  • [39] Sustained immune control in HBeAg-positive chronic hepatitis B patients who switched from long-term entecavir therapy to peginterferon alfa-2a (40KD): 1-year follow-up of the OSST study
    Han, Meifang
    Jiang, Jia-ji
    Hou, Jinlin
    Tan, Deming
    Sun, Yongtao
    Zhao, Mianzhi
    Ning, Qin
    HEPATOLOGY, 2013, 58 : 665A - 666A
  • [40] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
12345